http://www.senecaglobe.com/healthcare-stocks-grab-market-attentions-gilead-sciences-nasdaqgild-pernix-therapeutics-nasdaqptx/334819/
http://www.webbreakingnews.com/2016/08/12/fy2017-earnings-estimate-for-merck-co-mrk-issued-by-suntrust-banks/
http://dailyguideafrica.com/kenyan-infertility-victim-gets-support/
http://www.dailypolitical.com/2016/08/11/merck-co-mrk-receives-outperform-rating-from-sanford-c-bernstein/
http://www.dailypolitical.com/2016/08/11/merck-co-mrk-price-target-raised-to-57-00/
http://www.dailypolitical.com/2016/08/11/merck-co-mrk-price-target-raised-to-57-00-2/
http://www.dailypolitical.com/2016/08/11/merck-co-mrk-rating-increased-to-outperform-at-bmo-capital-markets/
http://www.4-traders.com//news/Merck-s-KEYTRUDA-pembrolizumab-Approved-by-the-European-Commission-for-Patients-with-Advanced-Non-S--22890396/
http://www.mondaq.com/canada/x/518376/Patent/But%2BFor%2BCould%2BAnd%2BWould%2BThe%2BPatent%2BDamages%2BApproach%2BTo%2BNoninfringing%2BAlternatives
http://www.marketwatch.com/story/biolinerx-reports-second-quarter-2016-financial-results-2016-08-11
http://www.dailypolitical.com/2016/08/11/investors-sell-merck-co-mrk-on-strength-after-insider-selling-2/
http://www.webbreakingnews.com/2016/08/11/sanford-c-bernstein-reaffirms-outperform-rating-for-merck-co-mrk/
http://www.fool.com/investing/2016/08/10/is-merck-co-a-better-buy-than-bristol-myers-follow.aspx?source=eptfxblnk0000004&utm_campaign=article&utm_medium=feed&utm_source=foxbusiness
http://investorplace.com/2016/08/6-pharmaceuticals-stocks-to-buy-now-4/
http://www.emailwire.com/release/261281-The-Most-Recent-Top-Six-Medical-Conspiracy-CoverUps-Exposed.html
http://www.prnewswire.com/news-releases/merck-manuals-releases-steps-to-preventing-waterborne-illnesses-300312097.html
http://www.4-traders.com//MERCK-LIMITED-9058973/news/Merck-Woman-s-has-arms-chopped-for-failure-to-bear-22887653/
http://www.4-traders.com//MERCK-LIMITED-9058973/news/Merck-Woman-amputated-for-failing-to-conceive-22884820/
http://www.finanznachrichten.de/nachrichten-2016-08/38286639-global-commercial-biotechnology-separation-systems-strategic-analysis-to-2020-liquid-chromatography-leads-biotechnology-separation-technologies-re-008.htm
http://www.webbreakingnews.com/2016/08/12/immune-design-corp-imdz-lifted-to-hold-at-zacks-investment-research/
http://www.prnewswire.co.uk/news-releases/research-and-markets---pneumococcal-vaccines-epidemiology-and-patient-based-market-2016-2025---prevnar-13-could-be-superseded-in-the-elderly-by-merck--cos-15-alent-conjugate-vaccine-590006831.html
http://www.4-traders.com//news/Pneumococcal-Vaccines-Epidemiology-and-Patient-Based-Market-2016-2025-Prevnar-13-will-continue-to-d--22895315/
http://www.barrons.com/articles/franklin-global-discovery-shelter-from-the-storm-1413608097
//www.macrumors.com/2016/08/11/apple-re-hires-evan-doll/
http://247wallst.com/healthcare-business/2016/08/11/why-jefferies-sees-3-big-biotechs-having-key-upside-catalysts-coming/
http://www.manufacturingchemist.com/news/article_page/Novel_lipid_altering_therapies_will_steer_acute_coronary_syndrome_market_beyond_12_billion_by_2022/120271
http://www.prnewswire.co.uk/news-releases/vaccines-market-growth-83-cagr-to-2021-led-by-n-america-589956521.html
http://www.xconomy.com/san-francisco/2016/08/10/heron-gains-fda-support-for-nausea-drug-after-a-year-under-review/
http://www.bloomberg.com/news/articles/2016-08-12/astrazeneca-rides-high-fueled-by-brexit-bristol-myers-failure
http://www.latimes.com/world/global-development/la-fg-global-river-blindness-oped-snap-story.html
http://www.benzinga.com/news/16/08/8340086/biogen-cancels-out-of-citigroup-conference-following-weeks-of-rumors
http://www.fool.com/investing/2016/08/11/better-buy-inovio-pharmaceuticals-inc-vs-incyte-co.aspx?source=eptfxblnk0000004&utm_campaign=article&utm_medium=feed&utm_source=foxbusiness
http://www.idownloadblog.com/2016/08/11/apple-rehires-evan-doll-for-health-projects/
http://economictimes.indiatimes.com/news/international/business/apple-hires-flipboard-co-founder-evan-doll-for-health-software-role/articleshow/53650238.cms
http://www.4-traders.com//news/Global-Nonstructural-Protein-4B-NS4B-Pipeline-Review-H1-2016-Gilead-Sciences-GSK-Inovio-John--22896961/
